UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): January 14, 2015
AMERICANN, INC.
-----------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 000-54231 27-4336843
------------------------ ---------------- ---------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
3200 Brighton Blvd., Unit 144
Denver, CO 80216
-------------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (303) 862-9000
--
1550 Larimer, Ste. 264
Denver, CO 80202
---------------------------------------------
(Former name or former address if changed since last report)
Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry Into a Material Definitive Agreement
On January 14, 2015, the Company entered into an agreement to purchase a
52.6 acre parcel of undeveloped land in Freetown, Massachusetts. The property is
located approximately 47 miles southeast of Boston. The Company plans to develop
the property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the
MMCC may include the construction of sustainable greenhouse cultivation,
processing, and infused product facilities that will be leased or sold to
Registered Marijuana Dispensaries under the Massachusetts Medical Marijuana
Program. Additional plans for the MMCC may include a testing laboratory, a
research facility, a training center and corporate offices.
The Company paid the seller $100,000 upon the signing of the agreement
which amount will be applied toward the purchase price of $4,000,000 at the
closing. The closing must take place on or before June 1, 2015.
The Company plans to develop comparable facilities in other states that
allow for the production and sale of cannabis. The Company's ability to develop
the MMCC, as well as its plans for other states, is contingent upon its ability
to obtain the capital required to fund the projects.
The Company does not cultivate, process or sell marijuana.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: February 12, 2015
AMERICANN, INC.
By:/s/ Timothy Keogh
--------------------------------------
Timothy Keogh, Chief Executive Office
